Vnitr Lek 2018, 64(6):679-683 | DOI: 10.36290/vnl.2018.093

Colorectal cancer screening

Štěpán Suchánek*, Tomáš Grega, Miroslav Zavoral
Interní klinika 1. LF UK a ÚVN - Vojenské fakultní nemocnice Praha

In developed countries, colorectal cancer represents one of the most common malignancy. Screening of colorectal cancer, as a tool of secondary prevention, lead to reduction of the incidence and mortality of this disease. It allows to capture not only the precancerous lesions, but also the earlier stages of colorectal cancer, which can be effectively treated. In the Czech Republic the National colorectal cancer screening program was launched in 2000. It is focused to asymptomatic individuals over 50 years old, who have a negative personal and family history of colorectal neoplasia. The basic tools of colorectal cancer screening in the Czech Republic include fecal occult blood test and colonoscopy. Introduction a population based screening program by addressed invitation in 2014 led to increase the participation of the target population for screening.

Keywords: address invitation; colorectal cancer; epidemiology; population based screening; screening tests

Received: October 31, 2017; Accepted: April 18, 2018; Published: June 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Suchánek Š, Grega T, Zavoral M. Colorectal cancer screening. Vnitr Lek. 2018;64(6):679-683. doi: 10.36290/vnl.2018.093.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Dušek L, Májek O, Mužík J et al. Epidemiologie a populační screening nádorů tlustého střeva a konečníku v České republice na podkladě nově dostupných dat. Gastroent Hepatol 2015; 69(6): 509-517. Go to original source...
    2. Conteduca V, Sansonno D, Russi S et al. Precancerous colorectal lesions (Review). Int J Oncol 2013; 43(4): 973-984. Dostupné z DOI: <http://dx.doi.org/10.3892/ijo.2013.2041>. Go to original source... Go to PubMed...
    3. Suchanek S, Grega T, Ngo O et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol 2016; 22(36): 8103-8111. Dostupné z DOI: <http://dx.doi.org/10.3748/wjg.v22.i36.8103>. Go to original source... Go to PubMed...
    4. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5): E359-E386. Dostupné z DOI: <http://dx.doi.org/10.1002/ijc.29210>. Go to original source... Go to PubMed...
    5. Ústav zdravotnických informací a statistiky ČR. Národní onkologický registr (NOR). Dostupné z WWW: <www.uzis.cz/registry-nzis/nor>.
    6. Pavlík T, Májek O, Büchler T et al. Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008. Cancer Epidemiol 2014; 38(1): 28-34. Dostupné z DOI: <http://dx.doi.org/10.1016/j.canep.2013.11.002>. Go to original source... Go to PubMed...
    7. van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135(1): 82-90. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2008.03.040>. Go to original source... Go to PubMed...
    8. Imperiale TF, Ransohoff DF, Itzkowitz SH et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351(26): 2704-2714. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa033403>. Go to original source... Go to PubMed...
    9. Segnan N, Armaroli P, Bonelli L et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial - SCORE. J Natl Cancer Inst 2011; 103(17): 1310-1322. <http://dx.doi.org/10.1093/jnci/djr284>. Erratum in J Natl Cancer Inst 2011; 103(24): 1903. Go to original source... Go to PubMed...
    10. Heresbach D, Djabbari M, Riou F et al. Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise. Gut 2011; 60(5): 658-665. Dostupné z DOI: <http://dx.doi.org/10.1136/gut.2010.225623>. Go to original source... Go to PubMed...
    11. Rex DK, Adler SN, Aisenberg J et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology 2015; 148(5): 948-957. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2015.01.025>. Go to original source... Go to PubMed...
    12. Carroll MR, Seaman HE, Halloran SP. Tests and investigations for colorectal cancer screening. Clin Biochem 2014; 47(10-11): 921-939. Dostupné z DOI: <http://dx.doi.org/10.1016/j.clinbiochem.2014.04.019>. Go to original source... Go to PubMed...
    13. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375(9726): 1624-1633. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140-6736(10)60551-X>. Go to original source... Go to PubMed...
    14. El Zoghbi M, Cummings LC. New era of colorectal cancer screening. World J Gastrointest Endosc 2016; 8(5): 252-258. Dostupné z DOI: <http://dx.doi.org/10.4253/wjge.v8.i5.252>. Go to original source... Go to PubMed...
    15. Kaminski MF, Polkowski M, Kraszewska E et al. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut 2014; 63(7): 1112-1119. Dostupné z DOI: <http://dx.doi.org/10.1136/gutjnl-2013-304965>. Go to original source... Go to PubMed...
    16. Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci 2015; 60(3): 681-691. Dostupné z DOI: <http://dx.doi.org/10.1007/s10620-015-3600-5>. Go to original source... Go to PubMed...
    17. Wilson JA. Colon Cancer Screening in the Elderly: When Do We Stop? Trans Am Clin Climatol Assoc 2010; 121: 94-103. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.